Priming and activation of human ovarian and breast cancer-specific CD8+ T cells by polyvalent Listeria monocytogenes-based vaccines.
about
The detection, treatment, and biology of epithelial ovarian cancerA ubiquitin independent degradation pathway utilized by a hepatitis B virus envelope protein to limit antigen presentationAttenuated Listeria monocytogenes: a powerful and versatile vector for the future of tumor immunotherapy.Cancer associated aberrant protein O-glycosylation can modify antigen processing and immune response.Proliferation behavior of E. coli in a three-dimensional in vitro tumor model.Tumor-associated antigen expressing Listeria monocytogenes induces effective primary and memory T-cell responses against hepatic colorectal cancer metastasesImmune-mediated regression of established B16F10 melanoma by intratumoral injection of attenuated Toxoplasma gondii protects against rechallenge.Cutting edge: rapid boosting of cross-reactive memory CD8 T cells broadens the protective capacity of the Flumist vaccine.Lung airway-surveilling CXCR3(hi) memory CD8(+) T cells are critical for protection against influenza A virusProspects and progress of Listeria-based cancer vaccines.ADAM metallopeptidase domain 17 (ADAM17) is naturally processed through major histocompatibility complex (MHC) class I molecules and is a potential immunotherapeutic target in breast, ovarian and prostate cancers.Tumor-Specific T Cell Dysfunction Is a Dynamic Antigen-Driven Differentiation Program Initiated Early during Tumorigenesis.Glucosidase inhibition enhances presentation of de-N-glycosylated hepatitis B virus epitopes by major histocompatibility complex class I in vitro and in woodchucks.Chromatin states define tumour-specific T cell dysfunction and reprogramming.
P2860
Q21198791-6C388843-0027-4C76-A06B-4B526DD7522AQ28744484-93135AC9-C66B-4638-BD08-F1B2711E73C9Q33633839-6AB8C4D1-24B6-4CCE-BCAE-D8BEB0EF52FDQ34494018-AC5F29C4-93B9-498D-897E-8CEF75D60270Q35708412-B5461E49-F8F1-47E8-BA64-4BBED05076AAQ35837818-7CF6A14A-536A-4EA4-AF7A-C58F8C17350FQ36487567-176448D3-A467-48A3-96CC-25703074ABD4Q36754401-24C179DC-889E-4217-9BFB-0B112DC72052Q37412380-7458A03F-11FA-49A0-9639-5EA345112F7CQ38617306-0CDBE3AF-CCF4-4182-91D9-D435DE93D032Q39617457-D037A6F6-0E63-44BC-A313-BC2E62498F66Q40577362-F95FD10A-9DA2-4592-AB16-795474E875A7Q42416375-AD123965-EE0B-4DE9-87D3-6597D2840E21Q46060358-7466C402-0DB6-44DC-B762-174CA0CB0863
P2860
Priming and activation of human ovarian and breast cancer-specific CD8+ T cells by polyvalent Listeria monocytogenes-based vaccines.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
2009年论文
@zh
2009年论文
@zh-cn
name
Priming and activation of huma ...... monocytogenes-based vaccines.
@en
Priming and activation of huma ...... monocytogenes-based vaccines.
@nl
type
label
Priming and activation of huma ...... monocytogenes-based vaccines.
@en
Priming and activation of huma ...... monocytogenes-based vaccines.
@nl
prefLabel
Priming and activation of huma ...... monocytogenes-based vaccines.
@en
Priming and activation of huma ...... monocytogenes-based vaccines.
@nl
P2093
P1476
Priming and activation of huma ...... monocytogenes-based vaccines.
@en
P2093
Angeles Alvarez Secord
Aykan Karabudak
Bill Hanson
Dirk G Brockstedt
Gomathinayagam Sinnathamby
Jennifer Zerfass
Jonathan Krakover
Martin Giedlin
Michael A Morse
Peter Lauer
P304
P356
10.1097/CJI.0B013E3181B0B125
P577
2009-10-01T00:00:00Z